William Pickering
Stock Analyst at Bernstein
(1.97)
# 3,157
Out of 5,113 analysts
33
Total ratings
60%
Success rate
-0.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BEAM Beam Therapeutics | Maintains: Outperform | $37 → $41 | $29.02 | +41.28% | 2 | Jan 21, 2026 | |
| VRTX Vertex Pharmaceuticals | Upgrades: Outperform | n/a | $477.91 | - | 6 | Jan 12, 2026 | |
| BBIO BridgeBio Pharma | Initiates: Outperform | $94 | $77.49 | +21.31% | 1 | Dec 11, 2025 | |
| BHVN Biohaven | Downgrades: Market Perform | $34 → $9 | $12.18 | -26.11% | 3 | Nov 6, 2025 | |
| BIIB Biogen | Maintains: Market Perform | $155 → $157 | $174.83 | -10.20% | 1 | Nov 3, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $95 → $88 | $56.68 | +55.26% | 5 | Nov 3, 2025 | |
| NTLA Intellia Therapeutics | Downgrades: Market Perform | $14 → $15 | $13.82 | +4.92% | 2 | Oct 28, 2025 | |
| RNA Avidity Biosciences | Downgrades: Market Perform | $52 → $72 | $72.46 | -0.63% | 1 | Oct 27, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $753 → $781 | $751.13 | +3.98% | 3 | Aug 27, 2025 | |
| SRPT Sarepta Therapeutics | Initiates: Market Perform | $13 | $21.31 | -39.00% | 1 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $314 → $310 | $349.58 | -11.32% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $27 → $24 | $65.58 | -63.40% | 2 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $81.92 | - | 2 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $6 | $1.45 | +313.79% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $53.69 | -18.05% | 1 | Mar 21, 2023 |
Beam Therapeutics
Jan 21, 2026
Maintains: Outperform
Price Target: $37 → $41
Current: $29.02
Upside: +41.28%
Vertex Pharmaceuticals
Jan 12, 2026
Upgrades: Outperform
Price Target: n/a
Current: $477.91
Upside: -
BridgeBio Pharma
Dec 11, 2025
Initiates: Outperform
Price Target: $94
Current: $77.49
Upside: +21.31%
Biohaven
Nov 6, 2025
Downgrades: Market Perform
Price Target: $34 → $9
Current: $12.18
Upside: -26.11%
Biogen
Nov 3, 2025
Maintains: Market Perform
Price Target: $155 → $157
Current: $174.83
Upside: -10.20%
BioMarin Pharmaceutical
Nov 3, 2025
Maintains: Outperform
Price Target: $95 → $88
Current: $56.68
Upside: +55.26%
Intellia Therapeutics
Oct 28, 2025
Downgrades: Market Perform
Price Target: $14 → $15
Current: $13.82
Upside: +4.92%
Avidity Biosciences
Oct 27, 2025
Downgrades: Market Perform
Price Target: $52 → $72
Current: $72.46
Upside: -0.63%
Regeneron Pharmaceuticals
Aug 27, 2025
Maintains: Outperform
Price Target: $753 → $781
Current: $751.13
Upside: +3.98%
Sarepta Therapeutics
Jul 29, 2025
Initiates: Market Perform
Price Target: $13
Current: $21.31
Upside: -39.00%
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $349.58
Upside: -11.32%
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $65.58
Upside: -63.40%
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $81.92
Upside: -
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $1.45
Upside: +313.79%
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $53.69
Upside: -18.05%